Top compounds associated with response to MYO1F


Feature Type Standardized
Nominal ANOVA
mRNA PD-0325901 gCSI pan-cancer AAC 0.24 1e-05
mRNA regorafenib CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.17 1e-05
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.16 1e-05
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.18 2e-05
mRNA BHG712 GDSC1000 pan-cancer AAC 0.14 2e-05
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.18 3e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA Nilotinib CCLE pan-cancer AAC 0.22 3e-05
Download CSV